GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandinavian ChemoTech AB (FRA:8V6) » Definitions » EV-to-EBITDA

Scandinavian ChemoTech AB (FRA:8V6) EV-to-EBITDA : -4.66 (As of May. 16, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Scandinavian ChemoTech AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Scandinavian ChemoTech AB's enterprise value is €4.35 Mil. Scandinavian ChemoTech AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.93 Mil. Therefore, Scandinavian ChemoTech AB's EV-to-EBITDA for today is -4.66.

The historical rank and industry rank for Scandinavian ChemoTech AB's EV-to-EBITDA or its related term are showing as below:

FRA:8V6' s EV-to-EBITDA Range Over the Past 10 Years
Min: -51.88   Med: -4.22   Max: -0.21
Current: -4.51

During the past 9 years, the highest EV-to-EBITDA of Scandinavian ChemoTech AB was -0.21. The lowest was -51.88. And the median was -4.22.

FRA:8V6's EV-to-EBITDA is ranked worse than
100% of 499 companies
in the Biotechnology industry
Industry Median: 7.15 vs FRA:8V6: -4.51

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-16), Scandinavian ChemoTech AB's stock price is €0.1595. Scandinavian ChemoTech AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.057. Therefore, Scandinavian ChemoTech AB's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Scandinavian ChemoTech AB EV-to-EBITDA Historical Data

The historical data trend for Scandinavian ChemoTech AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandinavian ChemoTech AB EV-to-EBITDA Chart

Scandinavian ChemoTech AB Annual Data
Trend Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -9.34 -10.46 -2.93 -2.78 -3.90

Scandinavian ChemoTech AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.29 -2.62 -3.89 -3.90 -2.41

Competitive Comparison of Scandinavian ChemoTech AB's EV-to-EBITDA

For the Biotechnology subindustry, Scandinavian ChemoTech AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scandinavian ChemoTech AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scandinavian ChemoTech AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Scandinavian ChemoTech AB's EV-to-EBITDA falls into.


;
;

Scandinavian ChemoTech AB EV-to-EBITDA Calculation

Scandinavian ChemoTech AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4.345/-0.932
=-4.66

Scandinavian ChemoTech AB's current Enterprise Value is €4.35 Mil.
Scandinavian ChemoTech AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scandinavian ChemoTech AB  (FRA:8V6) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Scandinavian ChemoTech AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.1595/-0.057
=At Loss

Scandinavian ChemoTech AB's share price for today is €0.1595.
Scandinavian ChemoTech AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.057.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Scandinavian ChemoTech AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Scandinavian ChemoTech AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Scandinavian ChemoTech AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 1, Medicon Village, Lund, SWE, 223 63
Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.

Scandinavian ChemoTech AB Headlines

No Headlines